Our 50,000 employees stand together with clinicians and caregivers around the world who are on the front lines of COVID-19.
"Our deepest gratitude goes to the healthcare providers and first responders battling the spread and impact of COVID-19, and my sincerest appreciation to our employees, whose tireless efforts are making a meaningful difference for patients globally," said Joe Almeida, chairman and CEO.
The COVID-19 pandemic is an unprecedented healthcare crisis that requires our complete support—even when obstacles seem the greatest. As a global leader in healthcare, we are focused on protecting the health and safety of our employees; increasing supply of our life-sustaining medicines and medical devices; and providing philanthropic support to impacted communities.
Leading in Unprecedented Times
“While our world is in uncharted territory, Baxter's path forward is clear. It is defined by our Mission to Save and Sustain Lives, just as it has been for nearly 90 years. We are doing everything we can to support our employees, patients, the healthcare system, and the communities we serve worldwide.
"Baxter’s medically essential portfolio places us on the front lines of this pandemic, and our team is rising to the challenge to make a meaningful difference. I stand in awe of all of my colleagues and how their passion and ingenuity is helping us respond in extraordinary ways,” said Joe Almeida, chairman and CEO.
Increasing Product Supply
The COVID-19 pandemic remains a challenge for many communities and healthcare systems around the world. We continue to support our hospital customers who are managing an influx of patients locally, especially in hot spots. Currently, our product supply levels in the U.S. are strong. Our team is also preparing for a potential second wave of infections, alongside our normal preparations for the flu and hurricane seasons. These proactive measures include building additional inventory of Baxter medical devices and drugs that have the potential to be in high demand.
- Baxter Obtains U.S. FDA EUA for Regiocit Replacement Solution Used in CRRT>
- Baxter Obtains U.S. FDA EUAs for HF20 Set and ST Set Used in CRRT>
- Baxter Obtains U.S. FDA EUA for Oxiris Blood Purification Filter>
- Baxter Shares Progress on Increasing Dialysis Supplies for Critically Ill COVID-19 Patients>
- Baxter Provides Update on COVID-19 Response>
Clinical Insights on the Novel Coronavirus
With expertise in hospital care, critical care medicine and dialysis, our in-house medical team is actively working with clinicians, healthcare societies, government authorities and key opinion leaders around the world to understand the unique clinical challenges created by COVID-19.
Supporting Our Communities
The Baxter International Foundation is supporting COVID-19 response efforts by providing financial support to groups on the front lines of the pandemic—addressing the needs of patients, health workers and communities. As of April 2020, we have provided $6 million in product donations and the Foundation has provided more than $2 million in grants to charitable organizations. This includes:
- A $1 million grant to Save the Children.
- Geographic-specific support to Direct Relief, Project Hope, Americares, the Red Cross, the iBio Institute and United Way.
- Funds for the UN Foundation/WHO COVID-19 Solidarity Response Fund, IsraAID, Partners in Health and World Vision’s COVID-19 Global Emergency Response.
People of Baxter Deliver on Our Mission During COVID-19
Our employees exemplify our mission to save and sustain lives every day. We stand together with healthcare professionals to battle COVID-19 around the world by helping ask and answer the tough medical questions, ensuring proper product training, helping increase product supply and in multitudes of other ways during this unprecedented time. We invite you to follow some of our employees, as they take extraordinary steps to deliver on our mission during the pandemic.